Quest Diagnostics Incorporated (DGX) Financials

DGX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 14.0 billion 7.6 billion
2023-09-30 13.5 billion 6.9 billion
2023-06-30 13.4 billion 7.1 billion
2023-03-31 12.8 billion 6.6 billion

DGX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 455.0 million 19.0 million
2023-09-30 102.0 million 18.0 million
2023-06-30 340.0 million 16.0 million
2023-03-31 -33.0 million 24.0 million

DGX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 192.0 million
2023-09-30 237.0 million
2023-06-30 249.0 million
2023-03-31 217.0 million

DGX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 686.0 million - 656.0 million
2023-09-30 143.0 million 3.9 billion 662.0 million
2023-06-30 126.0 million 3.8 billion 664.0 million
2023-03-31 175.0 million 4.0 billion 645.0 million

DGX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 113.0 million
2023-09-30 114.0 million
2023-06-30 114.0 million
2023-03-31 113.0 million

DGX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 72.0 million - 407.0 million -
2023-09-30 105.0 million - 376.0 million -
2023-06-30 104.0 million - 416.0 million -
2023-03-31 127.0 million - 439.0 million -

DGX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.3 billion 1.5 billion
2023-09-30 2.3 billion 1.5 billion
2023-06-30 2.3 billion 1.5 billion
2023-03-31 2.3 billion 1.6 billion

DGX

List: Contenders

Price: $137.55

52 week price:
119.59
148.62

Dividend Yield: 0.02%

5-year range yield:
0.02%
2.85%

Forward Dividend Yield: 2.18%

Payout Ratio: 40.05%

Payout Ratio Range:
9.80%
42.39%

Dividend Per Share: 3.00 USD

Earnings Per Share: 7.49 USD

P/E Ratio: 17.05

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.3 million

Ebitda: 346.0 million

Market Capitalization: 14.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 21

DGR3: 7.59%

DGR5: 6.76%

DGR10: 8.22%

Links: